05:24 PM EDT, 07/24/2024 (MT Newswires) -- Chemed ( CHE ) reported Q2 adjusted earnings late Wednesday of $5.47 per diluted share, up from $4.08 a year earlier.

Three analysts surveyed by Capital IQ expected $5.59.

Revenue for the quarter ended June 30 was $595.9 million, up from $553.8 million a year earlier.

Three analysts surveyed by Capital IQ expected $599.2 million.

The company now expects full-year 2024 adjusted EPS of $23.55 to $23.80, up from its previous guidance of $23.30 to $23.70.

Three analysts surveyed by Capital IQ expect $23.21.